ArticleCancer immunology, immunotherapy : CII2023

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study.

Ann W Silk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.